By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

IVD Medical Holding Limited (1931.HK)

HKSE Market Data in HKD, Fundamentals in CNY
$10.63
+$0.30
+2.90%
Last Update: 3 Sept 2025, 08:08
$17.24B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$1.05 - $12.86
52 Week Range

1931.HK Stock Price Chart

Explore IVD Medical Holding Limited interactive price chart. Choose custom timeframes to analyze 1931.HK price movements and trends.

1931.HK Company Profile

Discover essential business fundamentals and corporate details for IVD Medical Holding Limited (1931.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Distribution

IPO Date

12 Jul 2019

Employees

863.00

CEO

Kuk Sing Ho

Description

IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, Maintenance Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, molecular, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the clinical laboratories of hospitals; and maintenance services, such as maintenance and repair, installation, and end customer training services. In addition, it researches, develops, manufactures, and sells IVD analyzers and reagents under the IVD brand. The company offers its products to hospitals and healthcare institutions, logistics providers, and distributors. IVD Medical Holding Limited was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.

1931.HK Financial Timeline

Browse a chronological timeline of IVD Medical Holding Limited corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 11 Apr 2025

EPS came in at $0.10 , while revenue for the quarter reached $1.92B .

Earnings released on 29 Aug 2024

EPS came in at $0.10 , while revenue for the quarter reached $1.45B .

Dividend declared on 15 Jul 2024

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 25 Jul 2024.

Earnings released on 16 Mar 2024

EPS came in at $0.11 , while revenue for the quarter reached $1.89B .

Dividend declared on 4 Sept 2023

A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 13 Sept 2023.

Earnings released on 18 Aug 2023

EPS came in at $0.08 , while revenue for the quarter reached $1.49B .

Dividend declared on 23 May 2023

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 6 Jun 2023.

Earnings released on 17 Mar 2023

EPS came in at $0.11 , while revenue for the quarter reached $1.79B .

Dividend declared on 1 Sept 2022

A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 19 Sept 2022.

Earnings released on 19 Aug 2022

EPS came in at $0.07 , while revenue for the quarter reached $1.38B .

Dividend declared on 24 May 2022

A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 6 Jun 2022.

Earnings released on 31 Dec 2021

EPS came in at $0.09 , while revenue for the quarter reached $1.89B .

Dividend declared on 5 Oct 2021

A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 27 Oct 2021.

Earnings released on 30 Jun 2021

EPS came in at $0.07 , while revenue for the quarter reached $1.42B .

Dividend declared on 28 May 2021

A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 2 Jul 2021.

Earnings released on 31 Dec 2020

EPS came in at $0.11 , while revenue for the quarter reached $1.72B .

1931.HK Stock Performance

Access detailed 1931.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run